ACRV 8-K: SEC filing

Filed with the SEC on Nov 10, 2026 · accession 0001193125-26-455669

ACRV filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -0.6% by the first close after the filing.

Summary of the filing

Acrivon Therapeutics hosted a corporate R&D webcast with key opinion leaders to introduce its new immunology and inflammation programs, ACR-525 and PKCθ inhibitor, for eosinophilic esophagitis (EoE), and posted the accompanying presentation to its website.

For details, click here →How to read a 8-K →

Key details

RegistrantAcrivon Therapeutics, Inc.

Chief executive officer and presidentPeter Blume-Jensen, M.D., Ph.D.

Principal investigator and professor, gastroenterology and hepatology, amsterdam university medical centerArjan Bredenoord

Professor, department of medicine, division of gastroenterology and hepatology and director, center for esophageal diseases and swallowing, university of north carolina at chapel hillEvan Dellon

How ACRV stock reacted

Close before

$1.58

Nov 9, 2026

First close after

-0.63%

$1.57

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ACRV, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACRV?

Click here

Frequently asked questions

What did ACRV file with the SEC on Nov 10, 2026?

ACRV filed a 8-K (SEC filing). Acrivon Therapeutics hosted a corporate R&D webcast with key opinion leaders to introduce its new immunology and inflammation programs, ACR-525 and PKCθ inhibitor, for eosinophilic esophagitis (EoE), and posted the accompanying presentation to its website.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ACRV stock react to this filing?

ACRV closed at $1.58 before the filing and $1.57 on Nov 10, 2026 (-0.63%).

Other ACRV SEC filings

Get alerts when ACRV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ACRV overview ACRV analysis ACRV news Latest SEC filings